Theodore Ebel is listed as an executive officer on 8 SEC Form D filings by 2 issuers between Jun 2009 and Feb 2020: SKINMEDICA INC (Carlsbad, CA — pharmaceuticals — 2009–2012; $16.8M reported sold to 15 investors) and Colorescience Inc (Carlsbad, CA — other health care — 2013–2020; $15M reported sold to 53 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 11 years. Across those companies the filings report $31.8M sold in total.
Listed alongside Mary Fisher (8 shared filings), Brian H. Dovey (5 shared filings), David F. Hale (5 shared filings), Josh Baltzell (5 shared filings), Stephen Loomis (5 shared filings) and 28 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Theodore. Each name links to their own page.
1 of the issuers belongs to the sponsor group Colorescience (2 issuers, $18.3M reported sold, 2012–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Colorescience has 2 companies on file and $18.3M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 8 public filings for Theodore Ebel and found 4 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.